BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 16782455)

  • 1. Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway.
    Glass DA; Karsenty G
    Curr Top Dev Biol; 2006; 73():43-84. PubMed ID: 16782455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The low-density lipoprotein receptor-related protein 10 is a negative regulator of the canonical Wnt/beta-catenin signaling pathway.
    Jeong YH; Sekiya M; Hirata M; Ye M; Yamagishi A; Lee SM; Kang MJ; Hosoda A; Fukumura T; Kim DH; Saeki S
    Biochem Biophys Res Commun; 2010 Feb; 392(4):495-9. PubMed ID: 20093106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caprin-2 enhances canonical Wnt signaling through regulating LRP5/6 phosphorylation.
    Ding Y; Xi Y; Chen T; Wang JY; Tao DL; Wu ZL; Li YP; Li C; Zeng R; Li L
    J Cell Biol; 2008 Sep; 182(5):865-72. PubMed ID: 18762581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Wnt signaling and glucocorticoid-induced osteoporosis].
    Ohnaka K
    Clin Calcium; 2006 Nov; 16(11):1812-6. PubMed ID: 17079847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/beta-catenin signaling: components, mechanisms, and diseases.
    MacDonald BT; Tamai K; He X
    Dev Cell; 2009 Jul; 17(1):9-26. PubMed ID: 19619488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt signaling and osteoblastogenesis.
    Bodine PV; Komm BS
    Rev Endocr Metab Disord; 2006 Jun; 7(1-2):33-9. PubMed ID: 16960757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo analysis of Wnt signaling in bone.
    Glass DA; Karsenty G
    Endocrinology; 2007 Jun; 148(6):2630-4. PubMed ID: 17395705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis.
    Cheng JH; She H; Han YP; Wang J; Xiong S; Asahina K; Tsukamoto H
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G39-49. PubMed ID: 18006602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the Wnt signaling pathway in osteoblast commitment and differentiation.
    Yavropoulou MP; Yovos JG
    Hormones (Athens); 2007; 6(4):279-94. PubMed ID: 18055419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRP4 association to bone properties and fracture and interaction with genes in the Wnt- and BMP signaling pathways.
    Kumar J; Swanberg M; McGuigan F; Callreus M; Gerdhem P; Akesson K
    Bone; 2011 Sep; 49(3):343-8. PubMed ID: 21645651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation.
    Haÿ E; Laplantine E; Geoffroy V; Frain M; Kohler T; Müller R; Marie PJ
    Mol Cell Biol; 2009 Feb; 29(4):953-64. PubMed ID: 19075000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt5a mediated canonical Wnt signaling pathway activation in orthodontic tooth movement: possible role in the tension force-induced bone formation.
    Fu HD; Wang BK; Wan ZQ; Lin H; Chang ML; Han GL
    J Mol Histol; 2016 Oct; 47(5):455-66. PubMed ID: 27456852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton.
    Baron R; Rawadi G
    Endocrinology; 2007 Jun; 148(6):2635-43. PubMed ID: 17395698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
    Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
    Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinated action of CK1 isoforms in canonical Wnt signaling.
    Del Valle-Pérez B; Arqués O; Vinyoles M; de Herreros AG; Duñach M
    Mol Cell Biol; 2011 Jul; 31(14):2877-88. PubMed ID: 21606194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
    Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
    J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders.
    Levasseur R; Lacombe D; de Vernejoul MC
    Joint Bone Spine; 2005 May; 72(3):207-14. PubMed ID: 15850991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context.
    Mikels AJ; Nusse R
    PLoS Biol; 2006 Apr; 4(4):e115. PubMed ID: 16602827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt signaling: a key regulator of bone mass.
    Baron R; Rawadi G; Roman-Roman S
    Curr Top Dev Biol; 2006; 76():103-27. PubMed ID: 17118265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism of Wnt signaling pathway regulation by a truncated mutant of Axin2 in colorectal cancer].
    Wang FW; Wen L; Zhu SW; Yao Q; Cai YM; Ma G
    Ai Zheng; 2007 Oct; 26(10):1041-6. PubMed ID: 17927870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.